NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT03342417 2021-11-09Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer PatientsExcellaBio LLCPhase 2 Terminated5 enrolled